Kareem Saad
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kareem Saad
The proxy statement of GeneDx Holdings Corp. reports total compensation of $1,188,018 for Kareem Saad in fiscal 2023, including a base salary of $375,000. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Neogenomics Inc (NEO)
Source not stated
Current -
GeneDx Holdings Corp. (WGS)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
NEO
Leadership on record at GeneDx Holdings Corp.
Other people whose current roles at this company are on record from its filings.
- Eric Schadt CEO, Board Member
- Katherine Stueland CEO, Board Member
- Jason Ryan Chairman
- Kevin Feeley CFO
- Richard Miao CFO
- Bryan Dechairo COO
- Bryan Dechairo, Ph.D. COO
- Daniel Clark General Counsel
- Dennis Charney Board Member
- Dr. Emily Leproust Board Member
Leadership on record at Neogenomics Inc
Other people whose current roles at this company are on record from its filings.
- Chris Smith CEO, Board Member
- Christopher Smith CEO, Board Member
- Tony Zook CEO, Chairman, Board Member
- Warren Stone CEO, COO, Board Member
- Douglas M. VanOort Chairman
- Lynn A. Tetrault Chairman, Board Member
- Jeffrey S. Sherman CFO
- Jeffrey Sherman CFO
- Melody Harris COO
- Alicia Olivo General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | GeneDx Holdings Corp. (WGS) | Chief Transformation Officer | $375,000 | $1,188,018 |
| 2022 | GeneDx Holdings Corp. (WGS) | Chief Transformation Officer | $375,000 | $2,067,029 |
Recent activity
No call appearances or filed executive changes recorded yet.